Showing results (51-60 of 87) with videos related to
Sort By:
Pageof 9
Blood|September 24, 2024
Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studiesKatelyn Purvis, Yinmei Zhou, Seth E Karol, et al.Clinical Pharmacology and Therapeutics|December 17, 2024
Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic EthnicityMaud Maillard, Jenny Q Nguyen, Wenjian Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2023
Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALLShawn H R Lee, Emily Ashcraft, Wenjian Yang, et al.Leukemia|August 5, 2023
Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemiaKeito Hoshitsuki, Yinmei Zhou, April M Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic LeukemiaSatoshi Yoshimura, Yizhen Li, Shutaro Inoue, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2019
Antibodies Predict Pegaspargase Allergic Reactions and Failure of RechallengeYiwei Liu, Colton A Smith, John C Panetta, et al.British Journal of Haematology|August 29, 2014
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapySeth E Karol, Elaine Coustan-Smith, Xueyuan Cao, et al.Pharmacogenetics and Genomics|June 20, 2017
Genetics of pleiotropic effects of dexamethasoneLaura B Ramsey, Stan Pounds, Cheng Cheng, et al.The Lancet. Oncology|March 15, 2020
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation studySeth E Karol, Thomas B Alexander, Amit Budhraja, et al.Cancer|August 19, 2020
Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemiaSeth E Karol, Todd M Cooper, Paul E Mead, et al.Pageof 9